Funding
This study was mainly supported by Fundação de Apoio ao Ensino Pesquisa
e Assistência do Hospital das Clínicas da Faculdade de Medicina de
Ribeirão Preto da Universidade de São Paulo (FAEPA), Brasil, and
received partial support from the CVE - Centro de Vigilância
Epidemiológica “Prof. Alexandre Vranjac” da Secretaria da Saúde do
Estado de São Paulo (SES-SP). The funding sources didn’t have any role
in the writing, the decision to submit the manuscript for publication or
any other aspect pertinent to study conduction. There was no funding
from pharmaceutical companies or other agencies. All study data were
analysed by the corresponding author, as well as the final
responsibility for the decision to submit for publication.